XNAS · Materials · Specialty Chemicals
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-30 | Q1 2026 | 1.33 | 1.33 | +0.00% | $270.7M | ➖ Inline | +0.00% | -1.31% | -3.03% |
| 2026-02-20 | Q4 2025 | 1.28 | 1.31 | +2.34% | $263.6M | ✅ Beat | +4.69% | +5.91% | -4.09% |
| 2025-10-21 |
| Q3 2025 |
| 1.33 |
| 1.35 |
| +1.50% |
| $267.6M |
| ✅ Beat |
| — |
| — |
| — |
| 2025-07-31 | Q2 2025 | 1.25 | 1.27 | +1.60% | $255.5M | ✅ Beat | +1.09% | +4.58% | +6.31% |
| 2025-04-24 | Q1 2025 | 1.22 | 1.22 | +0.00% | $250.5M | ➖ Inline | -0.36% | +1.74% | +9.61% |
| 2025-02-21 | Q4 2024 | 1.11 | 1.13 | +1.80% | $240.0M | ✅ Beat | +1.12% | +6.29% | +0.48% |
| 2024-10-25 | Q3 2024 | 1.11 | 1.13 | +1.80% | $239.9M | ✅ Beat | -0.39% | +0.00% | +6.55% |
| 2024-07-26 | Q2 2024 | 1.03 | 1.09 | +5.83% | $234.1M | ✅ Beat | +0.43% | -5.15% | -4.20% |
Showing last 8 quarters.